About
ProTransit Nanotherapy develops a patented sustained-release microparticle drug delivery platform called Pro-MP™, which penetrates the skin and other tissues to locally deliver pharmaceutical actives such as antioxidants and hair growth stimulants with minimal systemic uptake.
Explore ProTransit Nanotherapy's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.